Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Stevanato Group S.p.A. - SIC # 3850 -
Ticker
Exchange
SIC #
Website
Latest Ticker
STVN
New York
3850
www.stevanatogroup.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Stevanato Group S.p.A.
Stevanato Group (STVN) Could Be 42% Undervalued Following Q3 Earnings
- Nov 4th, 2026 3:12 am
Stevanato Group Q3 Earnings Call Highlights
- Nov 4th, 2026 2:14 am
Stevanato (STVN) Q3 2026 Earnings Call Transcript
- Nov 3rd, 2026 2:17 pm
Stevanato Group SpA (STVN) (Q3 2026) Earnings Call Highlights: Revenue Climbs 8% as Non-GLP ...
- Nov 3rd, 2026 2:07 pm
Stevanato Group (STVN) Surpasses Q3 Earnings and Revenue Estimates
- Nov 3rd, 2026 5:00 am
Stevanato: Q3 Earnings Snapshot
- Nov 3rd, 2026 4:49 am
Stevanato Group Delivers 8% Revenue Growth for the Third Quarter of Fiscal 2026
- Nov 3rd, 2026 4:30 am
Stevanato Group S.p.A. (STVN) Rallies on 2Q26 Revenue Growth and EBITDA Margin Expansion
- Oct 28th, 2026 10:15 am
Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection
- Oct 27th, 2026 5:00 am
Aptar Pharma and Stevanato Group Collaborate to Help Accelerate Pre-Filled Syringe System Selection
- Oct 27th, 2026 5:00 am
Stevanato Group to Report Third Quarter 2026 Financial Results on November 3, 2026
- Oct 20th, 2026 2:30 pm
Ensera launches alliance network with SHL Medical, Stevanato Group, Ypsomed, Argonaut and American Injectables
- Oct 1st, 2026 7:00 am
United Therapeutics (UTHR) Moves 12.6% Higher: Will This Strength Last?
- Oct 1st, 2026 4:02 am
electroCore (ECOR) Stock Jumps 6.9%: Will It Continue to Soar?
- Sep 18th, 2026 7:09 am
Stevanato Group to Participate in Two Upcoming Investor Conferences
- Sep 8th, 2026 2:05 pm
Stevanato Group (STVN) Trades A Subsidiary For Margin Gains And Growth
- Sep 4th, 2026 6:01 am
Riverwater Sees a Market Overreaction in Stevanato Group (STVN) After Oral GLP-1 Launches
- Sep 1st, 2026 6:50 am
Stevanato Group (STVN) Could Be 16% Undervalued Following Earnings And Guidance Update
- Aug 10th, 2026 8:08 pm
How Investors Are Reacting To Stevanato Group (STVN) Trimmed Guidance And New GLP-1 Pen Approvals
- Aug 10th, 2026 7:12 am
Scroll